Veru reports cancer drug has high potential to reduce Covid-19 deaths

Dr. Mitchell Steiner, chief executive of drugmaker Veru, said a Phase 2 trial of VERU-111 showed an 82% relative reduction in Covid-19 patient mortality versus placebo.

source https://www.cnbc.com/2021/02/08/veru-reports-cancer-drug-has-high-potential-to-reduce-covid-19-deaths.html